Alexion, Astra Zeneca Rare Diseases, has been a leader in rare diseases for 30 years. Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialisation of life-changing medicines. We work alongside healthcare providers, patient advocacy organisations and governments to best serve patients by innovating and expanding our knowledge of rare diseases. Our goal is to bring hope to patients and families by delivering scientific advances
